TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27957559

Group type: EXPERIMENTAL
Intervention: Resin infiltration and fluoride varnish (RI+FV)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fluoride varnish only (FV)
Number of subjects: 81
Study: 24675911

Group type: EXPERIMENTAL
Intervention: Combined exercise circuit session at moderate intensity (3 laps of knee extension, bench press, knee flexion, rowing, squats, shoulder press, and 5 min of aerobic exercise at 75‐85% of age‐predicted maximum heart rate; resistance exercise at 50% of estimated 1 repetition maximum for 15 repetitions)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined exercise circuit session at moderate intensity
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control session with no exercise
Number of subjects: 20
Study: 22215918

Group type: EXPERIMENTAL
Intervention: Intensive Sleep Retraining (ISR)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Stimulus Control Therapy (SCT)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: ISR plus SCT
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (Sleep Hygiene)
Number of subjects: 79
Study: 20831416

Group type: EXPERIMENTAL
Intervention: Vignettes describing disclosure risk in informed consent statements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity of the survey topic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit mention of possible harms from disclosure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different wording of confidentiality assurance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental manipulations of risk and benefits perceptions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Survey topic
Number of subjects: 0
Study: 18213383

Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg daily for 12 months
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 16733278

Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Normal serum concentration of vitamin D, calcium, and phosphorus
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bone turnover markers
Number of subjects: 20
Study: 12888151

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy
Number of subjects: 103
Study: 10232298

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 8905428

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 100 mg by intravenous infusion 60 min before extubation
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (normal saline 3 cc)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Overall incidence
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Relative risk
Number of subjects: 77
Study: 1475621

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily for 7 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg for 7 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6399247

Group type: EXPERIMENTAL
Intervention: High feedback real-time ultrasound
Number of subjects: 129

Group type: COMPARATOR
Intervention: Low feedback real-time ultrasound
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Fetal movement at 16 weeks
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Delivery ratings of attachment to the neonate
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Reactions to the neonate at delivery and postpartum mood ratings
Number of subjects: 129
Study: 30747613

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose on day 1, then 90 mg twice daily on days 2-30, plus open-label aspirin 300-325 mg on day 1, then 75-100 mg once daily on days 2-30.
Number of subjects: 13000

Group type: COMPARATOR
Intervention: Aspirin 300-325 mg on day 1, then 75-100 mg once daily on days 2-30 (control group).
Number of subjects: 13000
Study: 29457538

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 60
Study: 26485203

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT) for osteoarthritis pain
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT) for osteoarthritis pain and insomnia
Number of subjects: 367

Group type: COMPARATOR
Intervention: Education-only control (EOC)
Number of subjects: 367
Study: 25319187

Group type: EXPERIMENTAL
Intervention: PUFA diet (sunflower oil rich in polyunsaturated fatty acids)
Number of subjects: 39

Group type: COMPARATOR
Intervention: SFA diet (palm oil rich in saturated fatty acids)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Whole group (independently of fat type)
Number of subjects: 39
Study: 22669351

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 24

Group type: COMPARATOR
Intervention: Travoprost
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tafluprost
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bimatoprost
Number of subjects: 24
Study: 20403637

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG)
Number of subjects: 136
Study: 17542047

Group type: EXPERIMENTAL
Intervention: Quetiapine (mean daily doses 357-496 mg/day)
Number of subjects: 4956

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4956

Group type: COMPARATOR
Intervention: Haloperidol (10.4 mg/day)
Number of subjects: 4956

Group type: COMPARATOR
Intervention: Risperidone (5.5 mg/day)
Number of subjects: 4956

Group type: COMPARATOR
Intervention: Chlorpromazine (552 mg/day)
Number of subjects: 4956

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 4956
Study: 16119514

Group type: EXPERIMENTAL
Intervention: Citalopram from Eurofarma Laboratórios Ltda. (test formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cipramil from Schering‐Plough (reference formulation)
Number of subjects: 0
Study: 12151431

Group type: EXPERIMENTAL
Intervention: HMG
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: rFSH
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Cetrorelix (0.25 mg to 0.5 mg)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 107
Study: 11225793

Group type: EXPERIMENTAL
Intervention: Optimal medical therapy plus dual chamber pacemaker programmed to optimal AV delay (Group 2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Optimal medical therapy (Group 1)
Number of subjects: 38
Study: 7562171

Group type: EXPERIMENTAL
Intervention: Triple gloving with kevlar glove liners
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Triple gloving with stainless steel glove liners
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Triple layer latex gloving
Number of subjects: 30

Group type: COMPARATOR
Intervention: Double latex gloving
Number of subjects: 30
Study: 2187002

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) + Diazepam (DIA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Chlorpromazine (CPZ) + Diazepam (DIA)
Number of subjects: 48
Study: 7203001

Group type: EXPERIMENTAL
Intervention: Home-based intervention program with nine months of weekly home visits
Number of subjects: 47
Study: 31513046

Group type: EXPERIMENTAL
Intervention: DET
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 2.0 μL NaFl
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Standard strip
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 5.0 μL NaFl
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 2.0 μL NaFl (verification study)
Number of subjects: 46
Study: 30500981

Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercise intervention (3 times a week for 16 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 28972083

Group type: EXPERIMENTAL
Intervention: Low-dose CpG-B with GM-CSF
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Low-dose CpG-B without GM-CSF
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Low-dose CpG-B with or without GM-CSF
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Low-dose CpG-B
Number of subjects: 52
Study: 26541915

Group type: EXPERIMENTAL
Intervention: LCZ696
Number of subjects: 8399

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 8399
Study: 23386328

Group type: EXPERIMENTAL
Intervention: Velaglucerase alfa 60 U/kg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Velaglucerase alfa 45 U/kg
Number of subjects: 25
Study: 21498386

Group type: EXPERIMENTAL
Intervention: Lactin‐V (Lactobacillus crispatus)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lactin‐V
Number of subjects: 100
Study: 19539115

Group type: EXPERIMENTAL
Intervention: Low-velocity, variable-amplitude spinal manipulation (LVVA-SM)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude spinal manipulation (HVLA-SM)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Minimal conservative medical care (MCMC)
Number of subjects: 240
Study: 17043959

Group type: EXPERIMENTAL
Intervention: Compound branch chain amino acid injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Compound amino acid (control)
Number of subjects: 50
Study: 14728606

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Sulfadoxine-pyrimethamine and Chloroquine (SP+CQ)
Number of subjects: 0
Study: 11766084

Group type: EXPERIMENTAL
Intervention: Immediate enteral nutrition (IEN)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Parenteral nutrition (PAN)
Number of subjects: 24
Study: 9266287

Group type: EXPERIMENTAL
Intervention: Angipress (50 mg)
Number of subjects: 18
Study: 8503523

Group type: EXPERIMENTAL
Intervention: GM-1 ganglioside
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 3822681

Group type: COMPARATOR
Intervention: Propranolol (3 mg/kg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Self-hypnosis
Number of subjects: 28
Study: 29934286

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention with telemonitoring guidance (weekly emails or phone calls)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Center-based CR
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (usual care with advice to remain physically active)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Home-based group
Number of subjects: 90
Study: 27373088

Group type: EXPERIMENTAL
Intervention: Budesonide treatment (1 ml budesonide suspension in gelatin sponges)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (gelatin sponges only)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Budesonide treatment
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 25093696

Group type: EXPERIMENTAL
Intervention: Airway wall thickness
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Emphysema
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Air trapping
Number of subjects: 1138
Study: 22835916

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation after axillary ultrasound
Number of subjects: 0
Study: 19879813

Group type: EXPERIMENTAL
Intervention: Pulsed-dose-rate (PDR) brachytherapy (PDRBT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: High-dose-rate (HDR) brachytherapy (HDRBT)
Number of subjects: 51
Study: 18443762

Group type: EXPERIMENTAL
Intervention: Intensified multi-factorial treatment
Number of subjects: 3057

Group type: COMPARATOR
Intervention: Not applicable (baseline characteristics)
Number of subjects: 3057
Study: 16707993

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 14667946

Group type: EXPERIMENTAL
Intervention: Walking forwards on a hard surface, eyes open
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Walking backwards on a foam support, eyes closed
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Walking backwards on a soft surface (foam)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Walking backwards
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Walking under increased locomotion difficulty
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Walking backwards on a soft surface
Number of subjects: 11
Study: 10750541

Group type: EXPERIMENTAL
Intervention: Writing about negative events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Writing about nonemotional events
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-writing control group
Number of subjects: 0
Study: 8782754

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal (prednisolone reduced to zero over about four months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (maintaining triple immunosuppression unchanged)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 1352363

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 400 mg/kg every 28 days
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 376
Study: 6424580

Group type: EXPERIMENTAL
Intervention: Induced Hypertension Chemotherapy (IHC) with a three-drug regimen (adriamycin, 5-FU, mitomycin C or adriamycin, vincristine, carboquone)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Induced Hypertension Chemotherapy (IHC) for stomach cancer
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group for stomach cancer
Number of subjects: 102
Study: 31826896

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle group sessions (9 weekly sessions)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Family voucher for a leisure centre (control)
Number of subjects: 43
Study: 30173303

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oxcarbazepine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 60
Study: 26702122

Group type: COMPARATOR
Intervention: Oral rehydration solution (ORS)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Full-fat milk
Number of subjects: 72

Group type: COMPARATOR
Intervention: Skimmed milk
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cola
Number of subjects: 72

Group type: COMPARATOR
Intervention: Diet cola
Number of subjects: 72

Group type: COMPARATOR
Intervention: Hot tea
Number of subjects: 72

Group type: COMPARATOR
Intervention: Iced tea
Number of subjects: 72

Group type: COMPARATOR
Intervention: Coffee
Number of subjects: 72

Group type: COMPARATOR
Intervention: Lager
Number of subjects: 72

Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sparkling water
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sports drink
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Still water
Number of subjects: 72
Study: 24745692

Group type: EXPERIMENTAL
Intervention: Spa therapy in addition to home exercise program (18 days)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Home exercise program alone
Number of subjects: 214
Study: 22594581

Group type: EXPERIMENTAL
Intervention: Estimated GFR (eGFR) below 45 mL/min/1.73 m(2)
Number of subjects: 4016

Group type: COMPARATOR
Intervention: eGFR above 45 mL/min/1.73 m(2)
Number of subjects: 4016
Study: 19808060

Group type: EXPERIMENTAL
Intervention: Group Attend CS+ (attended stimulus followed by aversive US)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group Attend CS- (ignored stimulus paired with aversive US)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-aversive reaction time task (Experiment 2)
Number of subjects: 0
Study: 17629203

Group type: EXPERIMENTAL
Intervention: Teacher-based group (Group T)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Parents-based group (Group P)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 3
Study: 15128684

Group type: EXPERIMENTAL
Intervention: Academic detailing visit
Number of subjects: 100

Group type: COMPARATOR
Intervention: Postal distribution of a guideline for prescribing asthma medication
Number of subjects: 100
Study: 11771023

Group type: EXPERIMENTAL
Intervention: Particle repositioning manoeuvre (PRM)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham PRM
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 71
Study: 9591542

Group type: EXPERIMENTAL
Intervention: Ceftazidime 50 mg/kg intravenously
Number of subjects: 25
Study: 7997065

Group type: COMPARATOR
Intervention: Ginkgo biloba extractum (GBE) 160 mg/d combined with memory training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piracetam 2.4 or 4.8 g/d combined with memory training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piracetam 3.3 g/d combined with normal school teaching and logopedic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piracetam 4.8 g/d combined with speech therapy
Number of subjects: 0
Study: 3276453

Group type: EXPERIMENTAL
Intervention: Intravenous adenosine infusion (10, 30, and 50 micrograms/kg/min for 6 min each)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 7
Study: 29239230

Group type: EXPERIMENTAL
Intervention: Scribe implementation (post-scribe cohort)
Number of subjects: 12671

Group type: COMPARATOR
Intervention: Pre-scribe cohort
Number of subjects: 12671
Study: 31434390

Group type: EXPERIMENTAL
Intervention: Nasal CPAP + moderate intensity aerobic exercise
Number of subjects: 112

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise
Number of subjects: 112
Study: 28991914

Group type: EXPERIMENTAL
Intervention: Topiramate (100mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (mannitol)
Number of subjects: 23
Study: 25315383

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX 50 mg/m(2) administered as a single intramuscular dose)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (saline solution administered in a single intramuscular dose)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 23721034

Group type: COMPARATOR
Intervention: Basic preventive program (dietary counselling, oral hygiene instructions, fluoride varnish application)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel in trays (additional measure)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 0.2% NaF gel in trays (additional measure)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Daily tooth brushing with 1% chlorhexidine gel (additional measure)
Number of subjects: 160
Study: 21964172

Group type: EXPERIMENTAL
Intervention: MAP0004 (orally inhaled dihydroergotamine)
Number of subjects: 902
Study: 19148734

Group type: EXPERIMENTAL
Intervention: Oral human immunoglobulin (IGOH) 140, 420, or 840 mg/day
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 16772757

Group type: EXPERIMENTAL
Intervention: 50-U BTX‐A
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 32
Study: 16330680

Group type: EXPERIMENTAL
Intervention: Low-saturated-fat diet
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control (unrestricted diet)
Number of subjects: 1062
Study: 12194548

Group type: EXPERIMENTAL
Intervention: 75 cm alimentary limb (Group A)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 150 cm alimentary limb (Group B)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 150 cm alimentary limb (Group C)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 250 cm alimentary limb (Group D)
Number of subjects: 110
Study: 9576972

Group type: EXPERIMENTAL
Intervention: hPTH(1‐34)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTH and estrogen combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTH treatment
Number of subjects: 0
Study: 7872170

Group type: EXPERIMENTAL
Intervention: Exercise ECG testing
Number of subjects: 191
Study: 2241053

Group type: EXPERIMENTAL
Intervention: Digital block
Number of subjects: 62

Group type: COMPARATOR
Intervention: Local infiltration
Number of subjects: 62
Study: 795438

Group type: EXPERIMENTAL
Intervention: 250 mug/kg delta‐9‐trans‐tetrahydrocannabinol (delta‐9‐THC) p.o.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: delta‐9‐THC
Number of subjects: 36
Study: 31357273

Group type: EXPERIMENTAL
Intervention: ATR FTIR spectroscopy with chemometric modeling for analysis of HMF in honey
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calibration and modeling efforts for ATR FTIR spectroscopy
Number of subjects: 0
Study: 27922285

Group type: EXPERIMENTAL
Intervention: Foley catheter alone
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Foley catheter plus oxytocin
Number of subjects: 108

Group type: COMPARATOR
Intervention: Oxytocin alone
Number of subjects: 108
Study: 26083546

Group type: EXPERIMENTAL
Intervention: Early reduction group (target LDL-C reduction achieved within 4 weeks)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Late reduction group (target LDL-C reduction not achieved within 4 weeks)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Late reduction group
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Early reduction group
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Percent reduction of LDL-C level during the initial 4 weeks
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Baseline LDL-C level
Number of subjects: 427
Study: 23551950

Group type: EXPERIMENTAL
Intervention: tacrolimus 0.1% ointment
Number of subjects: 20

Group type: COMPARATOR
Intervention: mometasone furoate cream
Number of subjects: 20